CASP3 and head and neck squamous cell carcinoma: The immunoblotting analysis showed that the administration of THL to HNSCC cells strikingly inactivated E2F1/Akt/SOX2 pathway and increased the activation of PARP and Caspase-3 (Figure 7C).